Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JAK2-IN-6是一种有效的、有选择性的 JAK2抑制剂(ic50为22.86 μg/mL),是一种多取代氨基噻唑衍生物。JAK2-IN-6抑制 JAK2酶的活性 ,通过干扰与 JAK2相关的信号通路,从而对 JAK2失调的特定疾病产生治疗作用, 对 JAK1和JAK3不显示出活性。JAK2是一种参与调节细胞生长和分裂的信号通路的蛋白质。JAK2的异常激活与多种疾病有关,包括某些类型的癌症和炎症性疾病。JAK2-IN-6对癌细胞具有抗增殖活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 413 | 现货 | ||
5 mg | ¥ 690 | 现货 | ||
10 mg | ¥ 1,120 | 现货 | ||
25 mg | ¥ 1,990 | 现货 | ||
50 mg | ¥ 2,890 | 现货 | ||
100 mg | ¥ 4,320 | 现货 | ||
500 mg | ¥ 8,900 | 现货 |
产品描述 | JAK2-IN-6, a polysubstituted aminothiazole derivative, is a potent and selective inhibitor of JAK2 (ic50 at 22.86 μg/mL). Jak2-in-6 inhibits the activity of JAK2 enzymes by interfering with Jak2-related signaling pathways, thereby producing therapeutic effects on the specific disease IN which JAK2 is dysregulated, and does not show activity on JAK1 and JAK3. JAK2 is a protein involved in signaling pathways that regulate cell growth and division. Abnormal activation of JAK2 has been linked to a variety of diseases, including some types of cancer and inflammatory diseases. JAK2-IN-6 has antiproliferative activity against cancer cells. |
靶点活性 | JAK2:22.86 μg/mL |
体外活性 | The treatment of JAK2-IN-6 (Compound B2; 6.3-50 μg/mL; 48 hours) demonstrates significant antiproliferative activity against PC-9, H1975, and PANC-1 cell lines. The IC50 values for PC-9, H1975, and PANC-1 cell lines are 18.1 μg/mL, 58.3 μg/mL, and 40.6 μg/mL, respectively [1]. |
别名 | JAK2-IN-6 |
分子量 | 335.83 |
分子式 | C14H10ClN3OS2 |
CAS No. | 353512-04-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 54.0 mg/mL (160.8 mM), when pH is adjusted to 5 with HCl. Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.9777 mL | 14.8885 mL | 29.777 mL | 74.4424 mL |
5 mM | 0.5955 mL | 2.9777 mL | 5.9554 mL | 14.8885 mL | |
10 mM | 0.2978 mL | 1.4888 mL | 2.9777 mL | 7.4442 mL | |
20 mM | 0.1489 mL | 0.7444 mL | 1.4888 mL | 3.7221 mL | |
50 mM | 0.0596 mL | 0.2978 mL | 0.5955 mL | 1.4888 mL | |
100 mM | 0.0298 mL | 0.1489 mL | 0.2978 mL | 0.7444 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
JAK2-IN-6 353512-04-6 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK JAK-2-IN-6 JAK2IN6 JAK2 IN 6 Inhibitor inhibitor inhibit